These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessing whether a clinical pharmacy program is meeting its goals. Fink A; Kosecoff J; Oppenheimer PR; Smith WE; Brodie DC Am J Hosp Pharm; 1982 May; 39(5):806-10. PubMed ID: 7081251 [TBL] [Abstract][Full Text] [Related]
6. Nurses' attitudes toward pharmaceutical services before and after decentralization. Ross MB; Ryan ML Am J Hosp Pharm; 1988 Feb; 45(2):351-6. PubMed ID: 3364435 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of direct pharmacist intervention on conversion from parenteral to oral histamine H2-receptor antagonist therapy. Kirking DM; Svinte MK; Berardi RR; Cornish LA; Chaffee BW; Ryan ML DICP; 1991 Jan; 25(1):80-4. PubMed ID: 1672572 [TBL] [Abstract][Full Text] [Related]
9. Perceptions, experiences, and expectations of physicians in hospital settings in Jordan regarding the role of the pharmacist. Tahaineh LM; Wazaify M; Albsoul-Younes A; Khader Y; Zaidan M Res Social Adm Pharm; 2009 Mar; 5(1):63-70. PubMed ID: 19285290 [TBL] [Abstract][Full Text] [Related]
10. Pharmacist adjustment of H2-receptor antagonist dosage to meet medical staff-approved criteria. Malcolm KE; Griffin CR; Bennett TA; Robertson LM Am J Hosp Pharm; 1994 Sep; 51(17):2152-4. PubMed ID: 7985692 [No Abstract] [Full Text] [Related]
12. Physician and patient perceptions of the route of administration of venous thromboembolism prophylaxis: results from an international survey. Cimminiello C; Anderson FA Thromb Res; 2012 Feb; 129(2):139-45. PubMed ID: 21816454 [TBL] [Abstract][Full Text] [Related]
13. A pharmacist-initiated program of intravenous to oral antibiotic conversion. Przybylski KG; Rybak MJ; Martin PR; Weingarten CM; Zaran FK; Stevenson JG; Levine DP Pharmacotherapy; 1997; 17(2):271-6. PubMed ID: 9085318 [TBL] [Abstract][Full Text] [Related]
14. Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy. Kane MP; Briceland LL; Garris RE; Favreau BN Am J Hosp Pharm; 1990 Sep; 47(9):2007-10. PubMed ID: 1977317 [TBL] [Abstract][Full Text] [Related]
15. Effect of exposure on physicians' attitudes toward clinical pharmacists. Ritchey FJ; Raney MR Am J Hosp Pharm; 1981 Oct; 38(10):1459-63. PubMed ID: 7294036 [TBL] [Abstract][Full Text] [Related]
16. Information on antineoplastic drugs for nononcologist physicians. Ballentine R; Primeaux J Am J Hosp Pharm; 1977 Aug; 34(8):839-43. PubMed ID: 900136 [TBL] [Abstract][Full Text] [Related]
17. Effect of pharmacist participation on a medical team on costs, charges, and length of stay. Haig GM; Kiser LA Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873 [TBL] [Abstract][Full Text] [Related]
18. Physicians' perceptions and knowledge of drug costs: results of a survey. Barclay LP; Hatton RC; Doering PL; Shands JW Formulary; 1995 May; 30(5):268-70, 272, 277-9. PubMed ID: 10151726 [TBL] [Abstract][Full Text] [Related]
19. Computer-based program for identifying medication orders requiring dosage modification based on renal function. Goldberg DE; Baardsgaard G; Johnson MT; Jolowsky CM; Shepherd M; Peterson CD Am J Hosp Pharm; 1991 Sep; 48(9):1965-9. PubMed ID: 1928142 [TBL] [Abstract][Full Text] [Related]
20. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy. Caldwell RD; Davis SK Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]